封面
市場調查報告書
商品編碼
1464628

生物成像市場,按成像方式、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Bio-imaging Market, By Imaging Modality, By End user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年生物影像市場規模為62.0343億美元,2024年至2032年年複合成長率為16.21%。

生物成像市場-市場動態

細胞生物學、生物化學和分子成像技術電腦分析的進步推動市場需求

全球生物成像市場在未來幾年擁有巨大的成長潛力,該技術有望成為診斷實踐的基石,帶來許多創新和商機。生物成像技術被認為是醫療保健和生物醫學研究領域的前景進步,有望推動經濟高效、緊湊、攜帶式和方便用戶使用的設備的開發。隨著細胞生物學、生物化學和分子成像技術的電腦分析不斷取得指數級進步,預計未來十年對這些技術的需求將大幅成長。生物成像市場的成長。隨著預期壽命的延長和生活方式的改變,癌症、心血管疾病和神經系統疾病等非傳染性疾病變得越來越普遍。例如,根據美國癌症協會2022年1月的報告,預計美國將有約19億新診斷癌症病例和609,360例癌症相關死亡

生物成像市場-關鍵見解

根據我們的研究分析師分享的分析,預計全球市場在預測期內(2024-2032 年)每年將以 16.21% 左右的年複合成長率成長

根據成像模式細分,磁振造影預計將在 2023 年顯示最大的市場佔有率

基於最終用戶細分,2023年診斷中心為主導類型

按地區分類,北美是 2023 年的主要收入來源

生物成像市場細分分析:

全球生物成像市場根據成像方式、最終用戶和地區進行細分。

根據影像方式,市場分為六類:磁振造影 (MRI)、電腦斷層掃描 (CT)、正子斷層掃描 (PET)、超音波、X 光、其他。到 2023 年,磁振造影 (MRI) 將成為一種主要的成像方式,以其多功能性、非侵入性和卓越的空間解析度而聞名,使其適合廣泛的臨床和研究最終用戶。 MRI 技術能夠以卓越的對比解析度實現軟組織、器官和解剖結構的詳細可視化,在不同醫學學科的診斷成像中確立了其不可或缺的地位。此外,MRI 能夠透過功能性 MRI (fMRI) 和磁振造影 (MRS) 等方法提供功能和分子見解,進一步增強了其在臨床和研究領域的功效。 MRI系統在醫院、診斷中心和研究機構的廣泛整合凸顯了其在生物影像市場的霸主地位。

市場根據最終用戶分為四類:醫院和診斷中心、學術和研究機構、製藥和生物技術公司、其他。就生物影像市場的最終用戶細分市場而言,醫院和診斷中心將在2023年成為主導細分市場。作用跨越無數的醫療條件。醫院和診斷中心是初級醫療保健機構,患者在這裡接受影像評估,以識別和管理疾病和損傷。隨著慢性病發病率的不斷上升以及對先進診斷影像服務的需求不斷成長,醫院和診斷中心持續投資於尖端的雙成像設備和技術。此外,將生物成像系統整合到電子健康記錄(EHR)和遠距醫療平台中可以增強其在醫療保健服務中的可及性和有效性。因此,醫院和診斷中心仍然是推動生物成像市場需求和擴張的主要最終用戶。

生物成像市場-地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

生物影像市場-競爭格局:

在生物成像市場,公司經常建立策略合作夥伴關係,以推進其成像技術、擴大其產品範圍並滿足不同的客戶需求。與學術機構和研究組織的合作促進了創新成像技術和應用的探索和驗證。與醫療保健提供者的合作有助於將成像系統無縫整合到臨床流程中,從而提高診斷精度和患者護理。此外,與製藥公司的聯盟透過提供用於篩選和分析的高通量成像解決方案來支持藥物發現和開發計劃。

最近的發展:

2024 年 1 月,領先的全自動儀器供應商 Biocare Medical 宣布與 HCR 成像技術的創造者 Molecular Instruments(R) (MI) 合作。此次合作將 Biocare Medical 在自動化生物成像系統方面的技術與 MI 的先進 HCR(TM) 產品套件相結合,在自動化原位雜合技術 (ISH) 和免疫組織化學 (IHC) 領域樹立了新基準。

目錄

第1章:生物影像市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 按影像模式分類的生物成像市場片段
    • 最終用戶的生物成像市場片段
    • 按國家/地區分類的生物成像市場片段
    • 按地區分類的生物成像市場片段
  • 競爭洞察

第 3 章:生物成像主要市場趨勢

  • 生物影像市場促進因素
    • 市場促進因素的影響分析
  • 生物影像市場限制
    • 市場限制影響分析
  • 生物成像市場機會
  • 生物成像市場未來趨勢

第 4 章:生物成像產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:生物影像市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:生物影像市場格局

  • 2023 年生物影像市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:生物成像市場 - 按影像模式

  • 概述
    • 按圖像模式分類的細分市場佔有率分析
    • 磁振造影 (MRI)
    • 電腦斷層掃描 (CT)
    • 正子斷層掃描 (PET)
    • 超音波
    • X光
    • 其他

第 8 章:生物成像市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診斷中心
    • 學術及研究機構
    • 製藥和生物技術公司
    • 其他

第 9 章:生物成像市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生物成像主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模與預測(以影像方式)
    • 北美市場規模和預測(按最終用戶)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生物成像主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(以影像方式)
    • 歐洲市場規模和預測(按最終用戶)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區生物成像主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(以影像方式)
    • 亞太地區市場規模和預測(按最終用戶)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲生物成像主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(以圖像方式)
    • 拉丁美洲市場規模和預測(按最終用戶)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲生物成像主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(以圖像方式)
    • 中東和非洲市場規模和預測(按最終用戶)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章:主要供應商分析 - 生物成像產業

  • 競爭儀表板
  • 公司簡介
    • Bracco Imaging SPA
    • Bayer HealthCare Pharmaceuticals
    • Esaote SpA
    • Digirad Corporation
    • FONAR Corporation
    • GE Healthcare
    • Hologic Inc
    • Hitachi Medical Corporation
    • Lantheus Medical Imaging, Inc.
    • Covidien Pharmaceuticals
    • Mindray Medical International Limited
    • Others

第 11 章:360 度分析師視角

第 12 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2425

REPORT HIGHLIGHT

Bio-imaging Market size was valued at USD 6,203.43 Million in 2023, expanding at a CAGR of 16.21% from 2024 to 2032.

Bio-imaging is the scientific discipline focused on obtaining functional and structural images of the human body. It employs various techniques and processes to capture detailed snapshots of human tissues and anatomy at the molecular level. This technology plays a crucial role in the diagnosis, treatment, and prevention of diseases by utilizing advanced imaging methods. Medical bio-imaging technology is widely utilized in the examination and diagnosis of numerous diseases, contributing to the establishment of a comprehensive database of the physiology and anatomy of living organisms for further research purposes. Molecular bio-imaging specifically deals with the spatial and temporal arrangement of macromolecules, incorporating various imaging technologies ranging from X-ray, elastography, and radiography to MRI, endoscopy, tactile imaging, positron emission tomography, and ultrasound.

Bio-imaging Market- Market Dynamics

Advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies to propel market demand

The global bio-imaging market holds immense growth potential in the coming years, with the technology poised to become a cornerstone of diagnostic practices, leading to numerous innovations and business opportunities. Bio-imaging techniques are considered promising advancements in healthcare and biomedical research, expected to drive the development of cost-effective, compact, portable, and user-friendly devices. As advancements in cell biology, biochemistry, and computer analysis for molecular imaging technologies continue to progress exponentially, the demand for these technologies is anticipated to rise significantly over the next decade.The increasing burden of chronic and infectious diseases worldwide is a major driving force behind the growth of the global bio-imaging market. With rising life expectancy and changing lifestyle patterns, non-communicable diseases such as cancer, cardiovascular diseases, and neurological disorders are becoming more prevalent. For example, according to a report by the American Cancer Society in January 2022, it is projected that there will be approximately 1.9 billion new cancer cases diagnosed and 609,360 cancer-related deaths in the U.S.

Bio-imaging Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.21% over the forecast period (2024-2032)

Based on Imaging Modality segmentation, Magnetic Resonance Imaging was predicted to show maximum market share in the year 2023

Based on End user segmentation, and diagnostic centers was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Bio-imaging Market- Segmentation Analysis:

The Global Bio-imaging Market is segmented on the basis of Imaging Modality, End user, and Region.

The market is divided into six categories based on Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Position Emission Tomography (PET), Ultrasound, X-ray, Others. In 2023, Magnetic Resonance Imaging (MRI) emerges as a predominant imaging modality renowned for its versatility, non-invasiveness, and exceptional spatial resolution, rendering it suitable for a broad spectrum of clinical and research End users. The technology of MRI enables detailed visualization of soft tissues, organs, and anatomical structures with remarkable contrast resolution, establishing its indispensability in diagnostic imaging across diverse medical disciplines. Furthermore, MRI's capability to furnish functional and molecular insights through methodologies like functional MRI (fMRI) and magnetic resonance spectroscopy (MRS) further amplifies its efficacy in both clinical and research domains. The extensive integration of MRI systems in hospitals, diagnostic centers, and research institutions underscores its hegemony in the bio-imaging market.

The market is divided into four categories based on End user: Hospitals & diagnostic centers, Academic & research institutes, Pharmaceutical & biotech companies, others. In terms of the end-user segment within the bio-imaging market, hospitals and diagnostic centers emerge as the dominant segment in 2023. This predominance is attributed to the indispensable role of bio-imaging technologies in clinical diagnosis, treatment planning, and disease monitoring across a myriad of medical conditions. Hospitals and diagnostic centers function as primary healthcare facilities where patients undergo imaging assessments for the identification and management of ailments and injuries. With the escalating incidence of chronic illnesses and the burgeoning demand for advanced diagnostic imaging services, hospitals and diagnostic centers persistently invest in cutting-edge bi-imaging equipment and technologies. Furthermore, the integration of bio-imaging systems into electronic health records (EHR) and telemedicine platforms enhances their accessibility and efficacy in healthcare delivery. Consequently, hospitals and diagnostic centers remain the principal end-users propelling demand and expansion in the bio-imaging market.

Bio-imaging Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Bio-imaging Market- Competitive Landscape:

In the bio-imaging market, companies frequently establish strategic partnerships to advance their imaging technologies, broaden their product offerings, and cater to diverse customer requirements. Collaborations with academic institutions and research organizations facilitate the exploration and validation of innovative imaging techniques and applications. Partnerships with healthcare providers facilitate the seamless integration of imaging systems into clinical processes, enhancing diagnostic precision and patient care. Additionally, alliances with pharmaceutical companies support drug discovery and development initiatives by offering high-throughput imaging solutions for screening and analysis.

Recent Developments:

In January 2024, Biocare Medical, a leading provider of fully automated instrumentation, announced a collaboration with Molecular Instruments(R) (MI), the creator of HCR Imaging technology. This cooperation combines Biocare Medical's skill in automated bio-imaging systems with MI's suite of advanced HCR(TM) Products, founding a new benchmark in automated in situ hybridization (ISH) and immunohistochemistry (IHC).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIO-IMAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHT

Bracco Imaging S.P.A

Bayer HealthCare Pharmaceuticals

Esaote S.p.A

Digirad Corporation

FONAR Corporation

GE Healthcare

Hologic Inc

Hitachi Medical Corporation

Lantheus Medical Imaging, Inc.

Covidien Pharmaceuticals

Mindray Medical International Limited

Others

GLOBAL BIO-IMAGING MARKET, BY IMAGING MODALITY - MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Position Emission Tomography (PET)
  • Ultrasound
  • X-ray
  • Others

GLOBAL BIO-IMAGING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & diagnostic centers
  • Academic & research institutes
  • Pharmaceutical & biotech companies
  • Others

GLOBAL BIO-IMAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Bio-imaging Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Bio-imaging Market Snippet by Image Modality
    • 2.1.2.Bio-imaging Market Snippet by End User
    • 2.1.3.Bio-imaging Market Snippet by Country
    • 2.1.4.Bio-imaging Market Snippet by Region
  • 2.2.Competitive Insights

3.Bio-imaging Key Market Trends

  • 3.1.Bio-imaging Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Bio-imaging Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Bio-imaging Market Opportunities
  • 3.4.Bio-imaging Market Future Trends

4.Bio-imaging Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Bio-imaging Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Bio-imaging Market Landscape

  • 6.1.Bio-imaging Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Bio-imaging Market - By Image Modality

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Image Modality, 2023 & 2032 (%)
    • 7.1.2.Magnetic Resonance Imaging (MRI)
    • 7.1.3.Computed Tomography (CT)
    • 7.1.4.Position Emission Tomography (PET)
    • 7.1.5.Ultrasound
    • 7.1.6.X-ray
    • 7.1.7.Others

8.Bio-imaging Market - By End User

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 8.1.2.Hospitals & diagnostic centers
    • 8.1.3.Academic & research institutes
    • 8.1.4.Pharmaceutical & biotech companies
    • 8.1.5.Others

9.Bio-imaging Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Bio-imaging Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Bio-imaging Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Bio-imaging Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Bio-imaging Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Bio-imaging Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Image Modality, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Bio-imaging Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bracco Imaging S.P.A
    • 10.2.2.Bayer HealthCare Pharmaceuticals
    • 10.2.3.Esaote S.p.A
    • 10.2.4.Digirad Corporation
    • 10.2.5.FONAR Corporation
    • 10.2.6.GE Healthcare
    • 10.2.7.Hologic Inc
    • 10.2.8.Hitachi Medical Corporation
    • 10.2.9.Lantheus Medical Imaging, Inc.
    • 10.2.10.Covidien Pharmaceuticals
    • 10.2.11.Mindray Medical International Limited
    • 10.2.12.Others

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Bio-imaging Market: Image Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Image Modality
  • TABLE Global Bio-imaging Market, by Image Modality 2019-2032 (USD Million)
  • TABLE Bio-imaging Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Bio-imaging Market, by End User 2019-2032 (USD Million)
  • TABLE Bio-imaging Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Bio-imaging Market, by Region 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE North America Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Europe Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Latin America Bio-imaging Market, by End User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by Image Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Bio-imaging Market, by End User, 2019-2032 (USD Million)